Discussion:
The vampire antiaging of elites
(too old to reply)
Taka
2017-01-08 03:25:53 UTC
Permalink
Raw Message


The Jews are known to consume the blood of gentile children on certain of their unholy days the so called "blood libel" being well documented in history. The children are tortured and slowly bled to death because it causes them to release some life-giving chemical into their blood.

There is a tremendous amount of information on this hideous practice on the internet. Of course they usually don't get caught but there have been many notable exceptions in history where they were caught, prosecuted and convicted and later expelled from many countries and regions.

Then there is the jewish circumcision ritual, which involves the genital mutilation of a baby and a Rabbi sucking the blood from it's bleeding penis. This is not some antisemitic meme it's a fact they admit to and that has caused thousands of babies to contract sexually transmitted diseases and dozens to die in documented cases.


Taka
2017-01-08 17:38:42 UTC
Permalink
Raw Message



Taka
2017-06-08 15:02:47 UTC
Permalink
Raw Message
Rich, old people want to use the blood of the youth in order to live longer

Once the talk of conspiracy theorists — the rich ingesting the blood of the young to foster longevity — is now a reality and an actual business in the United States. Not only is it a business but billionaires are actually admitting their interest in it.

“I’m looking into parabiosis stuff, which I think is really interesting. This is where they did the young blood into older mice and they found that had a massive rejuvenating effect,” Peter Thiel, the billionaire co-founder of PayPal and adviser to Donald Trump told Inc. magazine. “I think there are a lot of these things that have been strangely under-explored.”

But it’s no longer an experiment with just mice. The startup company by Jesse Karmazin, Ambrosia, is doing this with humans, and the rich are lining up to get the blood of the young.

As Vanity Fair reports, Ambrosia, which buys its blood from blood banks, now has about 100 paying customers. Some are Silicon Valley technologists, like Thiel, though Karmazin stressed that tech types aren’t Ambrosia’s only clients and that anyone over 35 is eligible for its transfusions.

As The Free Thought Project reported in January, a study published in Science and Nature Medicine revealed that transfusing young mouse blood into old mice can actually prevent the symptoms of aging. This groundbreaking discovery could lead to medical breakthroughs and the development of new medicines. However, a report from the Vice health news outlet “Tonic” has pointed out far more sinister applications for this knowledge.

It was suggested in the report that aging elites are using the blood of young people as a type of youth serum. Now, we know that they actually are using it.

A similar claim was made by journalist Jeff Bercovici last year, after he conducted several interviews with Silicon Valley aristocrats including Peter Thiel, and learned about this transfusion procedure called “parabiosis,” where the blood of young people is used to prevent aging.

“There are widespread rumors in Silicon Valley, where life-extension science is a popular obsession, that various wealthy individuals from the tech world have already begun practicing parabiosis, spending tens of thousands of dollars for the procedures and young-person-blood, and repeating the exercise several times a year,” Bercovici reported.

In his article, Bercovici also expressed concerns about a developing black market for young people’s blood.

While there is certainly nothing wrong with willing young adults selling their blood to the elite, the underlying theme of this practice has strong roots in the occult.

In most modern cultures, mass murder and human sacrifice still takes place out in the open under the cover of warfare, while many argue that cannibalism also still takes place but behind closed doors.

It is only in the past few hundred years that the practice of cannibalism among royals has not been publicized. In Europe, around the time of the American Revolution “corpse medicine” was very popular among the ruling class, Charles II even brewed his own.

Dr Richard Sugg of Durham University has conducted extensive research into the practice of corpse medicine among the royalty.

“The human body has been widely used as a therapeutic agent with the most popular treatments involving flesh, bone or blood. Cannibalism was found not only in the New World, as often believed, but also in Europe,” Sugg said.

“One thing we are rarely taught at school yet is evidenced in literary and historic texts of the time is this: James I refused corpse medicine; Charles II made his own corpse medicine; and Charles I was made into corpse medicine. Along with Charles II, eminent users or prescribers included Francis I, Elizabeth I’s surgeon John Banister, Elizabeth Grey, Countess of Kent, Robert Boyle, Thomas Willis, William III, and Queen Mary,” he added.

If this wasn’t strange enough, the current royal family of England claims to be direct descendants of Prince Vlad III Dracula of Wallachia (modern Romania). This was the sick and depraved ruler, Vlad the Impaler, who was known as a butcher and who eventually became the inspiration for the most famous vampire stories in history.

Aside from the gruesome historical and occult background of such practices, there is a lack of data that suggests the process even works. Despite Karmazin’s claims that “young blood is causing changes that appear to make the aging process reverse,” scientists have yet to identify a link between blood transfusions from the young and any tangible health benefits.

“There‘s just no clinical evidence [that the treatment will be beneficial], and you‘re basically abusing people‘s trust and the public excitement around this,” Stanford University neuroscientist Tony Wyss-Coray, who conducted a 2014 study of young blood plasma in mice, told Science magazine last summer, as reported by Vanity Fair.

SOURCE: http://www.thedailysheeple.com/no-longer-a-conspiracy-theory-elite-openly-paying-to-ingest-the-blood-of-the-young_062017
The Judge
2017-06-09 15:10:18 UTC
Permalink
Raw Message
Apparently this is not working well for the customers of the Ambrosia company:

An Update from Ambrosia on their Paid Plasma Transfusion Study

https://www.fightaging.org/archives/2017/06/an-update-from-ambrosia-on-their-paid-plasma-transfusion-study/

You might recall that Ambrosia was founded to obtain human data on blood plasma transfusions between young and old individuals. There has been the standard grumbling about their efforts being a paid trial without controls, but if one is only concerned with the identification or ruling out of large and reliable effects, that gets the job done. When the necessary millions in funding for formal studies cannot be found, as is often the case, then patient paid studies are a way to make some progress. If compelling enough results are produced, than it will be much easier to fund more rigorous efforts to quantify outcomes.
This recent commentary suggests that none of the results so far are either large enough or extensive enough to definitively be something other than the placebo effect, chance, or other items such as a patient making lifestyle changes. I think there is some skepticism regarding the potential effectiveness of transfusions of young blood in any case; the data is somewhat mixed, and underlying theory on what is going on still in flux. Recent research suggests that the effects observed in parabiosis studies of mice with joined circulatory systems are due to a dilution of harmful factors in old blood rather than a delivery of helpful factors from young blood, for example. If the case, that would mean that transfusions should produce very limited results at best. Still, obtaining data is the important thing, and that is what is being done here. Those complaining the loudest should put in the work to raise funds and run a study they way they would prefer to.
Older people who received transfusions of young blood plasma have shown improvements in biomarkers related to cancer, Alzheimer's disease and heart disease. Since August 2016, Ambrosia has been transfusing people aged 35 and older with plasma - the liquid component of blood - taken from people aged between 16 and 25. So far, 70 people have been treated, all of whom paid Ambrosia to be included in the study. The first results come from blood tests conducted before and a month after plasma treatment, and imply young blood transfusions may reduce the risk of several major diseases associated with ageing.
None of the people in the study had cancer at the time of treatment, however the Ambrosia team looked at the levels of certain proteins called carcinoembryonic antigens. These chemicals are found in the blood of healthy people at low concentrations, but in larger amounts these antigens can be a sign of having cancer. The team detected that the levels of carcinoembryonic antigens fell by around 20 per cent in the blood of people who received the treatment. However, there was no control group or placebo treatment in the study, and it isn't clear whether a 20 per cent reduction in these proteins is likely to affect someone's chances of developing cancer.
The team also saw a 10 per cent fall in blood cholesterol levels. "That was a surprise." This may help explain why a study by a different company last year found that heart health improved in old mice that were given blood from human teenagers. They also report a 20 per cent fall in the level of amyloids - a type of protein that forms sticky plaques in the brains of people with Alzheimer's disease. One participant, a 55-year-old man with early onset Alzheimer's, began to show improvements after one plasma treatment, and his doctors decided he could be allowed to drive a car again. An older woman with more advanced Alzheimer's is reportedly showing slow improvements, but her results have not been as dramatic.
Loading...